September 19, 2017 — Philips announced new OB/GYN innovations at the 27th World Congress on Ultrasound in Obstetrics and Gynecology (ISUOG), Sept. 16-19 in Vienna, Austria. New solutions include aBiometry AssistA.I, TouchVue and Tilt, as well as the eL18-4 transducer available on Philips’ Epiq 7 and 5 and Affiniti 70 ultrasound systems. These OB/GYN ultrasound solutions are designed to give clinicians more information earlier in pregnancy, making it easier to provide a confident diagnosis and overcome diagnostic challenges. They feature innovations such as anatomical intelligence, fingertip control and enhanced imaging versatility. Philips also debuted its new InnoSight touch-screen based diagnostic compact ultrasound, which offers exceptional image quality and performance, according to the company.
The portfolio of OB/GYN ultrasound tools being displayed at ISUOG 2017 includes:
- aBiometry AssistA.I., with its anatomical intelligence of fetal anatomy that preplaces measurement cursors on selected structures, reducing conventional measurement steps to streamline fetal measurement and reporting workflow;
- TrueVue with TouchVue interface, utilizes the Epiq touch panel, allowing users to intuitively interact and direct both the volume rotation and internal light source, creating photorealistic 3-D fetal images that allow deeper connection between the fetus and future parents;
- Tilt maximizes OB/GYN imaging versatility with a new 2-D Tilt feature of the 3D9-v3 transducer, allowing for lateral scanning of anatomical structures that are off-axis without having to manually angle the transducer to provide more comfort to the patient;
- The eL18-4 transducer features a multi-row array configuration for full electronic focusing of the elevation plan to provide imaging with exceptional detail resolution and tissue uniformity for clinical solutions including obstetrics; and
- The new InnoSight diagnostic compact ultrasound system features an ergonomic, intuitive design and clinical versatility to meet the mobility needs across a wide range of applications.
aBiometry AssistA.I, TouchVue and Tilt, and the eL18-4 transducer are U.S. Food and Drug Administration (FDA) 510(k) pending and not yet available in the U.S.
These innovative features complement the existing suite of OB/GYN ultrasound visualization tools from Philips, which will also be on display: GlassVue transparent 3-D visualization with its internal light source, which provides an early, more transparent view of the fetal anatomy; aRevealA.I. Ultrasound (AIUS) 3-D fetal face algorithm that automatically removes extraneous information to quickly and easily reveal the 3-D fetal face; and MaxVue, which allows clinicians to experience ultrasound imaging in 16:9 full high definition (FHD).
“Philips' latest OB/GYN ultrasound offerings provide clinicians with the tools to deliver diagnostic confidence needed to provide the best care for patients,” said Michael Ruma, M.D., maternal-fetal medicine specialist at Perinatal Associates of New Mexico. “The beginning of a new life is a special time, and Philips’ solutions allow clinicians to focus on the needs of each expecting mother.”
For more information: www.usa.philips.com/healthcare
November 20, 2025 
